Here is where intellectual honesty has to cut in both directions, because the point of this article is evidence, not advertising
The benefit was not observed in all-cause death (HR 0.99, 95% CI 0.841.15), hospitalization for heart failure (HR 1.04, 95% CI 0.891.22), cardiovascular death (HR 0.95, 95% CI 0.791.16), myocardial infarction (HR 0.88, 95% CI 0.711.08), stroke (HR 1.03, 95% CI 0.751.43) and death or hospitalization for HF (HR 1.07, 95% CI 0.781.46)
L-arginine is an amino acid that is a primary building block of protein in the body
Overall, the benefit-risk profile supports broad use of GLP-1-based therapies in MASLD across most patient subgroups, with individualized monitoring plans for high-risk populations
If you have Hashimotos or an underactive thyroid, consider making it a part of your hypothyroidism diet
The appropriate amount of the INK inhibitor is added and the formulation is mixed until a homogenous suspension is produced